NIH-funded research Fellowship grant

Understanding how certain parasite proteins affect severe malaria in children

Official title: Deciphering the roles of RIFIN and STEVOR parasite antigens in severe malaria pathogenesis via transcriptomics and immune profiling

Funded at University of Maryland Baltimore · NIH-10974027 · Data updated 2026-11-12

This study is looking at how certain proteins from malaria parasites affect how sick children in sub-Saharan Africa get from the disease, especially focusing on how different blood types, like A and O, play a role in this, to help find ways to better protect and treat those at higher risk.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Maryland Baltimore
NIH-funded
Lab location1 site (Baltimore, United States)
Project startJuly 1, 2023
Project endJune 30, 2025
Funding year2024
Award (this year)$35,459
NIH project number5F31AI178915-02
Project IDNIH-10974027 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children aged 0-11 years living in sub-Saharan Africa who are at risk of severe malaria.

Less likely to help

Patients outside the age range of 0-11 years or those not residing in sub-Saharan Africa may not benefit from this research.

What this research studies

This research investigates the roles of specific parasite proteins, RIFINs and STEVORs, in the severity of malaria among children in sub-Saharan Africa. By analyzing blood samples and immune responses, the study aims to uncover how these proteins interact with different blood types, particularly focusing on the increased risk associated with blood type A and the protective nature of blood type O. The research employs advanced transcriptomics and immune profiling techniques to gain insights into the mechanisms that lead to severe malaria. This could help identify children at higher risk and improve treatment strategies.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and management of severe malaria in children, potentially saving lives.

How similar studies have gone: Previous research has shown promising links between parasite antigens and malaria severity, suggesting that this approach could yield significant insights.

Where this research is happening

  • University of Maryland Baltimore
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Lawton, Jonathan — University of Maryland Baltimore
  • Study coordinator: Lawton, Jonathan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.